SLC5A2 and peripheral arterial disease: In summary, SGLT2 inhibitors confer vascular benefits in PAD through a multifaceted approach that includes improving endothelial function, exerting anti-inflammatory effects, reducing arterial stiffness, modulating VSMC activity, enhancing hemodynamic parameters, and promoting vascular repair mechanisms.